BridgeMD
New treatment option for Supraspinatus Injury
Official title Conservative Treatment in Patients With Supraspinatus Tendon Injury.
ClinicalTrials.gov ID: NCT06631976
What this study is testing
What is 1ml of Depo-Medrol® injection?
1ml of Depo-Medrol® injection is an investigational medicine, given as an injectable medicine, being studied as a potential treatment for supraspinatus injury.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- Rotator cuff injuries are a major cause of severe pain, often significantly impacting patients\' sleep quality. For patients waiting for surgery or those not eligible for operative treatment, conservative treatment is recommended.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 40 to 75
You may be able to join if
- Symptomatic partial incomplete thickness tear of the supraspinatus tendon, with a length below 1 cm and not exceeding 50% of the tendon thickness...
- Sleep disturbance symptoms for at least 1 month due to shoulder pain - PSQI score \> 5.
- Shoulder pain disrupting the quality of sleep.
- BMI \< 30.
- Age 40-75.
You likely can't join if
- Other accompanying pain symptoms.
- History of shoulder surgery.
- Coexistence of psychiatric or neurological disorders.
- Presence of comorbidities that may disrupt sleep.
- Presence of risk factors impairing tissue regeneration and increasing the likelihood of injury progression - osteoporosis, diabetes...
- Alcohol dependence, nicotine addiction, passive smoking.
See the full eligibility criteria
- Symptomatic partial incomplete thickness tear of the supraspinatus tendon, with a length below 1 cm and not exceeding 50% of the tendon thickness, confirmed by ultrasound examination.
- Sleep disturbance symptoms for at least 1 month due to shoulder pain - PSQI score \> 5.
- Shoulder pain disrupting the quality of sleep.
- BMI \< 30.
- Age 40-75.
- Other accompanying pain symptoms.
- History of shoulder surgery.
- Coexistence of psychiatric or neurological disorders.
- Presence of comorbidities that may disrupt sleep.
- Presence of risk factors impairing tissue regeneration and increasing the likelihood of injury progression - osteoporosis, diabetes, hypercholesterolemia.
- Alcohol dependence, nicotine addiction, passive smoking.
- Taking antibiotics from the fluoroquinolone group, sleep-affecting medications (such as melatonin, trazodone, zolpidem), antidepressants, antipsychotics, anxiolytics.
- Lack of patient consent, lack of cooperation, or impaired verbal-logical communication.
The study team makes the final eligibility decision.
Where it's taking place
- Lodz, Łódź Voivodeship, Poland
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 40 years to 75 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Lodz, Łódź Voivodeship, Poland. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.